Head and Neck Cancer: Should Patients Get PEG Access Prior to Therapy? VA pilot study could help clinicians make better-informed decisions to head off malnutritionSeptember 27, 2024Head & Neck/Thyroid CancersOncology
Transgender Women and Prostate Cancer: It’s ComplicatedSeptember 23, 2024Prostate CancerGenitourinary CancerOncology
Cancer Risk: Are Pesticides the New Smoking?September 20, 2024OncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
Implementation of a Prior Authorization Drug Review Process for Care in the Community Oncology PrescriptionsSeptember 12, 2024Oncology
VA Cancer Clinical Trials as a Strategy for Increasing Accrual of Racial and Ethnic Underrepresented GroupsSeptember 12, 2024Oncology
Posterior Reversible Encephalopathy Syndrome (PRES) Following Bevacizumab and Atezolizumab Therapy in Hepatocellular Carcinoma (HCC)September 12, 2024Oncology
CDK7 Inhibition in Patient-Derived Organoid Modeling of Biliary Tract CancersSeptember 12, 2024Oncology
The OCTAGON Project: A Novel VA-Based Telehealth Intervention for Oral Chemotherapy MonitoringSeptember 12, 2024Prostate CancerOncologyLung CancerLymphoma & Plasma Cell Disorders
Carboplatin as a Radiosensitizing Agent in Locally Advanced Head and Neck Cancer: Friendly to an Older Veteran PopulationSeptember 12, 2024OncologyHead & Neck/Thyroid Cancers
How to Make Keeping Up With the Drugs as Easy as Keeping Up With the Kardashians: Implementing a Local Oncology Drug Review CommitteeSeptember 12, 2024Oncology
PHASER Testing Initiative for Patients Newly Diagnosed With a GI MalignancySeptember 12, 2024OncologyColon and Rectal
Barriers from Detection to Treatment in Lung Cancer: A Single Veteran Affair Institution ReviewSeptember 12, 2024OncologyLung Cancer
